Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T
Published in Leukemia (01.08.2016)
Published in Leukemia (01.08.2016)
Get full text
Journal Article
Philadelphia chromosome-negative chronic myeloproliferative neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Vannucchi, A.M., Barbui, T., Cervantes, F., Harrison, C., Kiladjian, J.-J., Kröger, N., Thiele, J., Buske, C.
Published in Annals of oncology (01.09.2015)
Published in Annals of oncology (01.09.2015)
Get full text
Journal Article
Mutations and prognosis in primary myelofibrosis
Vannucchi, A M, Lasho, T L, Guglielmelli, P, Biamonte, F, Pardanani, A, Pereira, A, Finke, C, Score, J, Gangat, N, Mannarelli, C, Ketterling, R P, Rotunno, G, Knudson, R A, Susini, M C, Laborde, R R, Spolverini, A, Pancrazzi, A, Pieri, L, Manfredini, R, Tagliafico, E, Zini, R, Jones, A, Zoi, K, Reiter, A, Duncombe, A, Pietra, D, Rumi, E, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Tefferi, A
Published in Leukemia (01.09.2013)
Published in Leukemia (01.09.2013)
Get full text
Journal Article
European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
Hochhaus, A, Baccarani, M, Silver, R T, Schiffer, C, Apperley, J F, Cervantes, F, Clark, R E, Cortes, J E, Deininger, M W, Guilhot, F, Hjorth-Hansen, H, Hughes, T P, Janssen, J J W M, Kantarjian, H M, Kim, D W, Larson, R A, Lipton, J H, Mahon, F X, Mayer, J, Nicolini, F, Niederwieser, D, Pane, F, Radich, J P, Rea, D, Richter, J, Rosti, G, Rousselot, P, Saglio, G, Saußele, S, Soverini, S, Steegmann, J L, Turkina, A, Zaritskey, A, Hehlmann, R
Published in Leukemia (01.04.2020)
Published in Leukemia (01.04.2020)
Get full text
Journal Article
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
Kröger, N M, Deeg, J H, Olavarria, E, Niederwieser, D, Bacigalupo, A, Barbui, T, Rambaldi, A, Mesa, R, Tefferi, A, Griesshammer, M, Gupta, V, Harrison, C, Alchalby, H, Vannucchi, A M, Cervantes, F, Robin, M, Ditschkowski, M, Fauble, V, McLornan, D, Ballen, K, Popat, U R, Passamonti, F, Rondelli, D, Barosi, G
Published in Leukemia (01.11.2015)
Published in Leukemia (01.11.2015)
Get full text
Journal Article
Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia
Pfirrmann, M, Baccarani, M, Saussele, S, Guilhot, J, Cervantes, F, Ossenkoppele, G, Hoffmann, V S, Castagnetti, F, Hasford, J, Hehlmann, R, Simonsson, B
Published in Leukemia (01.01.2016)
Published in Leukemia (01.01.2016)
Get full text
Journal Article
Optomechanical reference accelerometer
Gerberding, O, Guzmán Cervantes, F, Melcher, J, Pratt, J R, Taylor, J M
Published in Metrologia (01.10.2015)
Published in Metrologia (01.10.2015)
Get full text
Journal Article
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Koschmieder, S, Mughal, T I, Hasselbalch, H C, Barosi, G, Valent, P, Kiladjian, J-J, Jeryczynski, G, Gisslinger, H, Jutzi, J S, Pahl, H L, Hehlmann, R, Maria Vannucchi, A, Cervantes, F, Silver, R T, Barbui, T
Published in Leukemia (01.05.2016)
Published in Leukemia (01.05.2016)
Get full text
Journal Article
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
Guglielmelli, P, Lasho, T L, Rotunno, G, Score, J, Mannarelli, C, Pancrazzi, A, Biamonte, F, Pardanani, A, Zoi, K, Reiter, A, Duncombe, A, Fanelli, T, Pietra, D, Rumi, E, Finke, C, Gangat, N, Ketterling, R P, Knudson, R A, Hanson, C A, Bosi, A, Pereira, A, Manfredini, R, Cervantes, F, Barosi, G, Cazzola, M, Cross, N C P, Vannucchi, A M, Tefferi, A
Published in Leukemia (01.09.2014)
Published in Leukemia (01.09.2014)
Get full text
Journal Article
A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis
Vannucchi, Alessandro M, Kantarjian, Hagop M, Kiladjian, Jean-Jacques, Gotlib, Jason, Cervantes, Francisco, Mesa, Ruben A, Sarlis, Nicholas J, Peng, Wei, Sandor, Victor, Gopalakrishna, Prashanth, Hmissi, Abdel, Stalbovskaya, Viktoriya, Gupta, Vikas, Harrison, Claire, Verstovsek, Srdan
Published in Haematologica (Roma) (01.09.2015)
Published in Haematologica (Roma) (01.09.2015)
Get full text
Journal Article
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
Passamonti, F, Giorgino, T, Mora, B, Guglielmelli, P, Rumi, E, Maffioli, M, Rambaldi, A, Caramella, M, Komrokji, R, Gotlib, J, Kiladjian, J J, Cervantes, F, Devos, T, Palandri, F, De Stefano, V, Ruggeri, M, Silver, R T, Benevolo, G, Albano, F, Caramazza, D, Merli, M, Pietra, D, Casalone, R, Rotunno, G, Barbui, T, Cazzola, M, Vannucchi, A M
Published in Leukemia (01.12.2017)
Published in Leukemia (01.12.2017)
Get full text
Journal Article
Activated carbon fibers as redox mediators for the increased reduction of nitroaromatics
Amezquita-Garcia, H.J., Razo-Flores, E., Cervantes, F.J., Rangel-Mendez, J.R.
Published in Carbon (New York) (01.04.2013)
Published in Carbon (New York) (01.04.2013)
Get full text
Journal Article
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
Barosi, G, Mesa, R A, Thiele, J, Cervantes, F, Campbell, P J, Verstovsek, S, Dupriez, B, Levine, R L, Passamonti, F, Gotlib, J, Reilly, J T, Vannucchi, A M, Hanson, C A, Solberg, L A, Orazi, A, Tefferi, A
Published in Leukemia (01.02.2008)
Published in Leukemia (01.02.2008)
Get full text
Journal Article
Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results
Hughes, T P, Leber, B, Cervantes, F, Spector, N, Pasquini, R, Clementino, N C D, Schwarer, A P, Dorlhiac-Llacer, P E, Mahon, F-X, Rea, D, Guerci-Bresler, A, Kamel-Reid, S, Bendit, I, Acharya, S, Glynos, T, Dalal, D, Branford, S, Lipton, J H
Published in Leukemia (01.11.2017)
Published in Leukemia (01.11.2017)
Get full text
Journal Article
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
PARDANANI, A, VANNUCCHI, A. M, PASSAMONTI, F, CERVANTES, F, BARBUI, T, TEFFERI, A
Published in Leukemia (01.02.2011)
Published in Leukemia (01.02.2011)
Get full text
Journal Article
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
Harrison, C N, Vannucchi, A M, Kiladjian, J-J, Al-Ali, H K, Gisslinger, H, Knoops, L, Cervantes, F, Jones, M M, Sun, K, McQuitty, M, Stalbovskaya, V, Gopalakrishna, P, Barbui, T
Published in Leukemia (01.03.2017)
Published in Leukemia (01.03.2017)
Get full text
Journal Article
pyCHARMM: Embedding CHARMM Functionality in a Python Framework
Buckner, Joshua, Liu, Xiaorong, Chakravorty, Arghya, Wu, Yujin, Cervantes, Luis F., Lai, Thanh T.
Published in Journal of chemical theory and computation (27.06.2023)
Published in Journal of chemical theory and computation (27.06.2023)
Get full text
Journal Article